XOMA vs GYRE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 19, 2026
XOMA
GYRE
Investment Advisor Scores
GYRE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | XOMA | GYRE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 21.4592 | 78.125 | XOMA |
| PEG Ratio | -0.42 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -22.6% | -2.1% | GYRE |
| Earnings Growth | 207.9% | 166.2% | XOMA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 46.3/100 | 29.0/100 | XOMA |
| Profit Margin | 69.6% | -19.3% | XOMA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
XOMA
NeutralMixed signals - no dominant trend phase, RSI 35
GYRE
MarkupPrice above SMA50, rising 50-day trend (1.9% over 20 days), RSI 59
Fundamentals Snapshot
| Metric | XOMA | GYRE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -803.4 | -29.4 |
| Trailing P/E | 28.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.2% | 0.0% |
| Gross Margin | 1.0% | 0.9% |
| Operating Margin | 0.0% | -0.5% |
| EPS | 1.57 | -0.21 |
| Dividend Yield | — | — |